Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers

Abstract Background Cyclin-dependent kinase inhibitor 2C (CDKN2C) was identified to participate in the occurrence and development of multiple cancers; however, its roles in small cell lung carcinoma (SCLC) remain unclear. Methods Differential expression analysis of CDKN2C between SCLC and non-SCLC w...

Full description

Bibliographic Details

Published in:	BMC Pulmonary Medicine
Main Authors:	Guo-Sheng Li, Gang Chen, Jun Liu, Deng Tang, Jin-Hua Zheng, Jing Luo, Mei-Hua Jin, Hua-Song Lu, Chong-Xi Bao, Jia Tian, Wu-Sheng Deng, Jing-Wei Fu, Yue Feng, Neng-Yong Zeng, Hua-Fu Zhou, Jin-Liang Kong
Format:	Article
Language:	English
Published:	BMC 2022-06-01
Subjects:	Cancer Prognosis Survival Marker Expression
Online Access:	https://doi.org/10.1186/s12890-022-02036-5